About Cell Proliferation Kits
Cell proliferation kits are assays that deliver the quick and deep quantification of cell proliferation and viability. They are used to analyze pharmaceutical compounds and toxic agents and quantify cell proliferation in the context of growth factors, nutrients, and mitogens.
Technavio’s analysts forecast the global cell proliferation kits market to grow at a CAGR of 7.75% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global cell proliferation kits market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Cell Proliferation Kits Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Bio-Rad Laboratories
• F. Hoffmann-La Roche
• GENERAL ELECTRIC
• Merck
• PerkinElmer
• Thermo Fisher Scientific
Market driver
• Increasing adoption of toxicology testing in food industry
• For a full, detailed list, view our report
Market challenge
• Lack of skilled professionals
• For a full, detailed list, view our report
Market trend
• Increasing importance of promotional activities
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: MARKET SEGMENTATION BY APPLICATION
• Overview
• Comparison by application
• Pharmaceutical and biotechnology companies
• Academic institutes and research laboratories
• Others
• Market opportunity by application
PART 08: CUSTOMER LANDSCAPE
PART 09: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas
• EMEA
• APAC
• Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 12: MARKET TRENDS
• Increasing importance of promotional activities
• Emerging economies offering opportunities for growth
• Increasing geriatric population driving biomedical research
PART 13: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Bio-Rad Laboratories
• F. Hoffmann-La Roche
• GENERAL ELECTRIC
• Merck
• PerkinElmer
• Thermo Fisher Scientific
• Other prominent vendors
PART 15: APPENDIX
• List of abbreviations
List of Exhibits
Exhibit 01: Parent market
Exhibit 02: Global cell analysis market: Segments
Exhibit 03: Market characteristics
Exhibit 04: Global cell proliferation kits market: Segments
Exhibit 05: Market definition: Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global cell proliferation kits market 2017-2022 ($ millions)
Exhibit 09: Global cell proliferation kits market: Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition: Five forces 2017
Exhibit 18: Market condition: Five forces 2022
Exhibit 19: Global cell proliferation kits market: Segmentation by application 2017-2022 (% share)
Exhibit 20: Comparison by application
Exhibit 21: Global cell proliferation kits market by pharmaceutical and biotechnology companies 2017-2022 ($ millions)
Exhibit 22: Factors driving growth of global pharmaceutical and biotechnology market
Exhibit 23: Global cell proliferation kits market by pharmaceutical and biotechnology companies: Year-over-year growth 2018-2022 (%)
Exhibit 24: Global cell proliferation kits market by academic institutes and research laboratories 2017-2022 ($ millions)
Exhibit 25: Global cell proliferation kits market by academic institutes and research laboratories: Year-over-year growth 2018-2022 (%)
Exhibit 26: Global cell proliferation kits market by others 2017-2022 ($ millions)
Exhibit 27: Global cell proliferation kits market by others: Year-over-year growth 2018-2022 (%)
Exhibit 28: Market opportunity by application
Exhibit 29: Customer landscape
Exhibit 30: Global cell proliferation kits market: Segmentation by geography 2017-2022 (% share)
Exhibit 31: Regional comparison
Exhibit 32: Cell proliferation kits market in Americas 2017-2022 ($ millions)
Exhibit 33: Cell proliferation kits market in Americas: Year-over-year growth 2018-2022 (%)
Exhibit 34: Top-three countries in Americas
Exhibit 35: Cell proliferation kits market in EMEA 2017-2022 ($ millions)
Exhibit 36: Cell proliferation kits market in EMEA: Year-over-year growth 2018-2022 (%)
Exhibit 37: Top-three countries in EMEA
Exhibit 38: Cell proliferation kits market in APAC 2017-2022 ($ millions)
Exhibit 39: Cell proliferation kits market in APAC: Year-over-year growth 2018-2022 (%)
Exhibit 40: Top-three countries in APAC
Exhibit 41: Market opportunity
Exhibit 42: Vendor landscape
Exhibit 43: Landscape disruption
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: Bio-Rad Laboratories: Overview
Exhibit 48: Bio-Rad laboratories: Business segments
Exhibit 49: Bio-Rad Laboratories: Organizational developments
Exhibit 50: Bio-Rad Laboratories: Geographic focus
Exhibit 51: Bio-Rad Laboratories: Segment focus
Exhibit 52: Bio-Rad laboratories: Key offerings
Exhibit 53: F. Hoffmann-La Roche: Overview
Exhibit 54: F. Hoffmann-La Roche: Business segments
Exhibit 55: F. Hoffmann-La Roche: Organizational developments
Exhibit 56: F. Hoffmann-La Roche: Geographic focus
Exhibit 57: F. Hoffmann-La Roche: Segment focus
Exhibit 58: F. Hoffmann-La Roche: Key offerings
Exhibit 59: GENERAL ELECTRIC: Overview
Exhibit 60: GENERAL ELECTRIC: Business segments
Exhibit 61: GENERAL ELECTRIC: Organizational developments
Exhibit 62: GENERAL ELECTRIC: Geographic focus
Exhibit 63: GENERAL ELECTRIC: Segment focus
Exhibit 64: GENERAL ELECTRIC: Key offerings
Exhibit 65: Merck: Overview
Exhibit 66: Merck: Business segments
Exhibit 67: Merck: Organizational developments
Exhibit 68: Merck: Geographic focus
Exhibit 69: Merck: Segment focus
Exhibit 70: Merck: Key offerings
Exhibit 71: PerkinElmer: Overview
Exhibit 72: PerkinElmer: Business segments
Exhibit 73: PerkinElmer: Organizational developments
Exhibit 74: PerkinElmer: Geographic focus
Exhibit 75: PerkinElmer: Segment focus
Exhibit 76: PerkinElmer: Key offerings
Exhibit 77: Thermo Fisher Scientific: Overview
Exhibit 78: Thermo Fisher Scientific: Business segments
Exhibit 79: Thermo Fisher Scientific: Organizational developments
Exhibit 80: Thermo Fisher Scientific: Geographic focus
Exhibit 81: Thermo Fisher Scientific: Segment focus
Exhibit 82: Thermo Fisher Scientific: Key offerings
